BioCentury
ARTICLE | Clinical News

Swine influenza A: Interim Phase II/III data

November 23, 2009 8:00 AM UTC

Interim data from an ongoing U.S. Phase II/III trial showed that a single 7.5 µg dose of unadjuvanted swine influenza A (H1N1) vaccine met immune response criteria in adults and elderly subjects >=18 ...